Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPγS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide

Neurochemistry International

Volumn 34, Issue 6, 1999, Pages 473-482

  Romero, J ^a   Berrendero, F ^a   Garcia Gil L ^a   Lin, S Y ^b   Makriyannis, A ^b   Ramos, J A ^a   Fernandez Ruiz J J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Autoradiography; Cannabinoid receptor agonist stimulated 35S GTP S binding; Cannabinoid receptor binding; Cannabinoid receptor mRNA levels; Chronic exposure; In situ hybridization; R methanandamide; Tolerance

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MESSENGER RNA; METHANANDAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; BRAIN CORTEX; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM NUCLEUS; CONTROLLED STUDY; DRUG TOLERANCE; ENANTIOMER; GLOBUS PALLIDUS; HIPPOCAMPUS; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SUBSTANTIA NIGRA;

ANIMALS; ARACHIDONIC ACIDS; BASAL GANGLIA; BRAIN; CANNABINOIDS; CEREBELLUM; CEREBRAL CORTEX; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MORPHOLINES; NAPHTHALENES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER;

ANIMALIA;

EID: 0033020235     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00020-0     Document Type: Article

References (24)

1. Abadji V., Lin S., Taha G., Griffin G., Stevenson L.A., Pertwee R.G., Makriyannis A. (R)-Methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. Journal of Medicinal Chemistry. 37:1994;1889-1893.
2. 9-tetrahydrocannabinol without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacology, Biochemistry & Behavior. 46:1993;575-579.
3. Brady L.S., Herkenham M., Long J.B., Rothman R.B. Chronic morphine increases μ-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Research. 477:1989;382-386.
4. Deutsch D.G., Chin S.A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochemical Pharmacology. 46:1993;791-796.
5. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
6. Dewey W.L. Cannabinoid pharmacology. Pharmacological Reviews. 38:1986;151-178.
7. 9-tetrahydrocannabinol. Brain Research. 697:1995;83-90.
8. Jansen E.M., Haycock D.A., Ward S.J., Seybold U.S. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Research. 575:1992;93-102.
9. de Miguel R., Romero J., Muñoz R.M., García-Gil L., González S., Villanua M.A., Makriyannis A., Ramos J.A., Fernández-Ruiz J.J. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic γ-aminobutiric acid (GABA) inputs. Biochemical Pharmacology. 56:1998;1331-1338.
10. Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Research. 616:1993;293-302.
11. Paxinos G., Watson C. The rat brain in stereotaxic co-ordinates. 1986;Academic Press.
12. Pertwee R.G. Tolerance and dependence on psychotropic cannabinoids. Pratt J. The Biological Bases of Drug Tolerance and Dependence. 1991;119-164 Academic Press.
13. Pertwee R.G. Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors. Pertwee R.G. Cannabinoid Receptors. 1995;1-34 Academic Press.
14. 9-tetrahydrocannabinol. Pharmacology, Biochemistry & Behavior. 47:1994;33-40.
15. 9-tetrahydrocannabinol. Pharmacology, Biochemistry & Behavior. 51:1995;731-737.
16. Romero J., García-Palomero E., Lin S.Y., Ramos J.A., Makriyannis A., Fernández-Ruiz J.J. Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand. Life Sciences. 58:1996;1249-1257.
17. 9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Molecular Brain Research. 46:1997;100-108.
18. Romero J., García-Palomero E., Berrendero F., García-Gil L., Hernández M.L., Ramos J.A., Fernández-Ruiz J.J. Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse. 26:1997;317-323.
19. 9-tetrahydrocannabinol. Synapse. 30:1998;298-308.
20. Rubino T., Massi P., Patrini G., Venier I., Giagnoni G., Parolaro D. Chronic CP-55,940 alters cannabinoid receptor-mRNA in the rat brain: an in situ hybridization study. Neuroreport. 5:1994;2493-2496.
21. 35S]-GTPγS autoradiography in rat brain. Journal of Neuroscience. 16:1996;8057-8066.
22. Tietz E.I., Rosenberg H.C., Chin T.H. Autoradiographic localization of benzodiazepine receptor down-regulation. Journal of Pharmacology and Experimental Therapeutics. 236:1986;284-292.
23. 9-tetrahydrocannabinol-induced antinociception. J. Pharmacol. Exp. Ther. 273:1995;1235-1244.
24. 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptor. Brain Research. 544:1991;145-149.